Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New aciclovir prodrugs and their use in ocular viral infections

July 2, 2003

Novartis Ophthalmics obtains development and marketing license for Lucentis

June 27, 2003

Enrollment completed in phase II/III European trial of Trabio

June 19, 2003

Synthetic retinal peptide improves functional activity in diabetic retinopathy

June 19, 2003

Improved maintenance of vision reported with anecortave acetate in exudative AMD

June 13, 2003

Novel EP2 receptor agonists with utility in glaucoma therapy discovered at Allergan

June 10, 2003

Preclinical results for microplasmin in posterior vitreous detachment

May 29, 2003

Selectin inhibitor shows potential in the management of uveitis

May 23, 2003

Intravitreal Posurdex safe and effective in persistent macular edema

May 22, 2003

New data on the efficacy and safety of verteporfin phototherapy in macular degeneration

May 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...